EDGAR Filing Documents for 0001571049-17-005587

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001571049-17-005587

Filing Date

2017-06-01

Accepted

2017-06-01 17:06:35

Documents

Period of Report

2017-05-30

Document Format Files

Seq	Description	Document	Type	Size
1	OWNERSHIP DOCUMENT	t1701732_x5-f4.html	4
1	OWNERSHIP DOCUMENT	t1701732_x5-f4.xml	4	3959
	Complete submission text file	0001571049-17-005587.txt		5463

Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922

Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330

Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SEMS CAPITAL 7 DEY STREET, SUITE 1101 NEW YORK NY 10017

Business Address

Type: 4 | Act: 34 | File No.: 000-50626 | Film No.: 17885543